异烟肼和利福平联合作用引起的肝毒性。
Hepatotoxicity caused by the combined action of isoniazid and rifampicin.
作者信息
Askgaard D S, Wilcke T, Døssing M
机构信息
Medical Department P, Bispebjerg Hospital, Copenhagen, Denmark.
出版信息
Thorax. 1995 Feb;50(2):213-4. doi: 10.1136/thx.50.2.213.
Abstract
A 35 year old black Somalian woman with miliary tuberculosis developed hepatotoxicity after a few days of treatment with isoniazid, rifampicin, pyrazinamide, and ethambutol. After withdrawal of all drugs the liver profile returned to normal and remained so after challenge with isoniazid. Hepatotoxicity recurred when rifampicin was added, but it was well tolerated when reintroduced without isoniazid.
摘要
一名35岁的索马里黑人女性患有粟粒性肺结核，在接受异烟肼、利福平、吡嗪酰胺和乙胺丁醇治疗几天后出现肝毒性。停用所有药物后，肝功能检查恢复正常，再次使用异烟肼进行激发试验后仍保持正常。添加利福平时肝毒性复发，但在不使用异烟肼的情况下重新引入利福平时耐受性良好。
相似文献
1
Hepatotoxicity caused by the combined action of isoniazid and rifampicin.异烟肼和利福平联合作用引起的肝毒性。
Thorax. 1995 Feb;50(2):213-4. doi: 10.1136/thx.50.2.213.
2
3
[Fulminating hepatitis caused by administration of isoniazid and rifampicin in a patient under chronic treatment with barbiturates].[一名长期接受巴比妥类药物治疗的患者在服用异烟肼和利福平后引发暴发性肝炎]
Ned Tijdschr Geneeskd. 1980 Jun 21;124(25):1008-12.
4
Hepatotoxicity of rifampin-pyrazinamide and isoniazid preventive therapy and tuberculosis treatment.利福平-吡嗪酰胺及异烟肼预防性治疗和结核病治疗的肝毒性
Clin Infect Dis. 2004 Aug 15;39(4):488-96. doi: 10.1086/422645. Epub 2004 Jul 30.
5
[Drug-induced hepatitis during a treatment associating isoniazid and rifampicin].[异烟肼和利福平联合治疗期间的药物性肝炎]
Ann Pediatr (Paris). 1972 Apr;19(4):307-11.
6
7
[Fulminant hepatitis in the course of antitubercular treatment (apropos of 2 cases)].抗结核治疗过程中的暴发性肝炎（附2例报告）
Dakar Med. 1995;40(2):129-31.
8
Enlarged cervical lymph nodes and elevated liver chemistry tests: a therapeutic dilemma.颈部淋巴结肿大与肝功能检查结果升高：一个治疗难题。
Ann Hepatol. 2004 Jul-Sep;3(3):118-20.
9
Inactive hepatitis B surface antigen carrier state and hepatotoxicity during antituberculosis chemotherapy.抗结核化疗期间的非活动性乙肝表面抗原携带者状态与肝毒性
Chest. 2005 Apr;127(4):1304-11. doi: 10.1378/chest.127.4.1304.
10
Fatal hepatitis after treatment with isoniazid and rifampicin in a patient on anticonvulsant therapy.
Tubercle. 1983 Jun;64(2):125-8. doi: 10.1016/0041-3879(83)90037-5.
引用本文的文献
1
A literature review of liver function test elevations in rifampin drug-drug interaction studies.利福平药物相互作用研究中肝功能试验升高的文献复习。
Clin Transl Sci. 2022 Jul;15(7):1561-1580. doi: 10.1111/cts.13281. Epub 2022 May 9.
2
Something Old, Something New: Ion Channel Blockers as Potential Anti-Tuberculosis Agents.旧药新用：离子通道阻滞剂作为潜在的抗结核药物。
Front Immunol. 2021 Jun 24;12:665785. doi: 10.3389/fimmu.2021.665785. eCollection 2021.
3
Diallyl trisulfide protects the liver against hepatotoxicity induced by isoniazid and rifampin in mice by reducing oxidative stress and activating Kupffer cells.二烯丙基三硫化物通过减轻氧化应激和激活库普弗细胞来保护小鼠肝脏免受异烟肼和利福平诱导的肝毒性。
Toxicol Res (Camb). 2016 Apr 1;5(3):954-962. doi: 10.1039/c5tx00440c. eCollection 2016 May 1.
4
Oxidative Stress and First-Line Antituberculosis Drug-Induced Hepatotoxicity.氧化应激与一线抗结核药物性肝损伤。
Antimicrob Agents Chemother. 2018 Jul 27;62(8). doi: 10.1128/AAC.02637-17. Print 2018 Aug.
5
Protective effects of salep against isoniazid liver toxicity in wistar rats.沙雷普对Wistar大鼠异烟肼肝毒性的保护作用。
J Tradit Complement Med. 2017 Jun 21;8(1):239-243. doi: 10.1016/j.jtcme.2017.06.001. eCollection 2018 Jan.
6
Tuberculosis of the Liver, Biliary Tract, and Pancreas.肝脏、胆道和胰腺结核。
Microbiol Spectr. 2017 Jan;5(1). doi: 10.1128/microbiolspec.TNMI7-0025-2016.
7
A Comparative Analysis of Drug-Induced Hepatotoxicity in Clinically Relevant Situations.临床相关情况下药物性肝毒性的比较分析
PLoS Comput Biol. 2017 Feb 2;13(2):e1005280. doi: 10.1371/journal.pcbi.1005280. eCollection 2017 Feb.
8
Ayurvedic management of pulmonary tuberculosis: A systematic review.阿育吠陀医学对肺结核的管理：一项系统评价。
J Intercult Ethnopharmacol. 2015 Nov 13;5(1):86-91. doi: 10.5455/jice.20151107020621. eCollection 2016 Jan-Feb.
9
Antituberculosis drug-induced hepatotoxicity in children.儿童抗结核药物性肝毒性
Pediatr Rep. 2011 Jun 16;3(2):e16. doi: 10.4081/pr.2011.e16.
10
Hepatic safety of antibiotics used in primary care.初级保健中使用的抗生素的肝脏安全性。
J Antimicrob Chemother. 2011 Jul;66(7):1431-46. doi: 10.1093/jac/dkr159. Epub 2011 May 17.
本文引用的文献
1
Toxicity form rifampicin plus isoniazid and rifampicin plus ethambutol therapy.利福平加异烟肼及利福平加乙胺丁醇疗法的毒性。
Tubercle. 1971 Sep;52(3):182-90. doi: 10.1016/0041-3879(71)90041-9.
2
Rifampin-induced release of hydrazine from isoniazid. A possible cause of hepatitis during treatment of tuberculosis with regimens containing isoniazid and rifampin.利福平诱导异烟肼释放肼。含异烟肼和利福平方案治疗结核病期间肝炎的一个可能原因。
Am Rev Respir Dis. 1986 Jun;133(6):1072-5. doi: 10.1164/arrd.1986.133.6.1072.
3
Drug-induced liver disease.
Med Clin North Am. 1989 Jul;73(4):775-92. doi: 10.1016/s0025-7125(16)30638-1.
4
Toxic hepatitis with isoniazid and rifampin. A meta-analysis.
Chest. 1991 Feb;99(2):465-71. doi: 10.1378/chest.99.2.465.
5
Isoniazid-related hepatitis: a U.S. Public Health Service cooperative surveillance study.异烟肼相关性肝炎：一项美国公共卫生服务合作监测研究。
Am Rev Respir Dis. 1978 Jun;117(6):991-1001. doi: 10.1164/arrd.1978.117.6.991.
Zotero 插件